0

Human Vascular Adhesion proteın-1 (VAP-1): Serum Levels for Hepatocellular Carcinoma in Non-Alcoholic and Alcoholic Fatty Liver Disease

Ozgur Kemik, Aziz Sümer, Ahu Sarbay Kemik, Veyis Itik, Ahmet Cumhur Dulger, Sevim Purisa, Sefa Tuzun

World J Surg Oncol. 2010 Sep 17;8:83.

PMID: 20849600

Abstract:

Background:
The incidence of hepatocellular cancer in complicated alcoholic and non-alcoholic fatty liver diseases is on the rise in western countries as well in our country. Vascular adhesion protein-1 (VAP-1) levels have been presented as new marker. In our study protocol, we assessed the value of this serum protein, as a newly postulant biomarker for hepatocellular cancer in patients with a history of alcoholic and non-alcoholic fatty liver diseases.
Methods:
Pre-operative serum samples from 55 patients with hepatocellular cancer with a history of alcoholic and non-alcoholic fatty liver diseases and patients with cirrhosis were assessed by a quantitative sandwich ELISA using anti-VAP-1 mAbs. This technique is used to determine the levels of soluble VAP-1 (sVAP-1) in the serum.
Results:
sVAP-1 levels were evaluated in patients with hepatocellular cancer and liver cirrhosis. There was a significant difference in mean VAP-1 levels between groups. Serum VAP-1 levels were found higher in patients with hepatocellular cancer.
Conclusion:
These findings indicate that the serum level of sVAP-1 might be a beneficial marker of disease activity in chronic liver diseases.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
IAR42414800 VAP-1 human VAP-1 human Price
qrcode